Fantastic news this morning on Rett results.....with the rare pediatric disease designation and potential for accelerated approval, this could become the next Sarepta.....I bet the Rett Syndrome community is thrilled today!
(2)
(0)
Anavex Life Sciences Corp. (AVXL) Stock Research Links
